Sale!

ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ABCC6 gene plays a critical role in the regulation of calcium and phosphate levels in the body, influencing the development and maintenance of healthy tissues, including the arteries. Mutations in the ABCC6 gene can lead to a rare genetic disorder known as Generalized Arterial Calcification of Infancy Type 2 (GACI Type 2). This condition is characterized by extensive calcification of the arteries, which can lead to cardiovascular issues early in life, including heart attacks and strokes, even in infancy or childhood.

To diagnose this condition accurately and promptly, genetic testing targeting the ABCC6 gene is crucial. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the ABCC6 gene that are associated with Generalized Arterial Calcification of Infancy Type 2. This test is an invaluable tool for early detection, allowing for timely intervention and management of the condition to prevent severe complications.

The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the ABCC6 gene. Results from this test can provide essential information for families affected by GACI Type 2, including risk assessment for family members and potential treatment options to manage the condition.

Given the rare nature of GACI Type 2 and the specialized testing required, DNA Labs UAE plays a crucial role in providing access to this important diagnostic tool within the region, supporting affected families in navigating the challenges associated with this genetic condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test

At DNA Labs UAE, we offer the ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test at a cost of 4400.0 AED.

Test Details

The ABCC6 gene is responsible for producing a protein called the ATP-binding cassette sub-family C member 6. Mutations in this gene can lead to a condition known as arterial calcification type 2, generalized, infantile. This rare genetic disorder is characterized by abnormal calcification (hardening) of the arteries throughout the body.

Arterial calcification type 2, generalized, infantile can result in various complications such as narrowing of the blood vessels, reduced blood flow, and increased risk of heart attacks and strokes.

NGS Technology

We use NGS (Next-Generation Sequencing) technology for this genetic test. NGS genetic testing allows for the simultaneous analysis of multiple genes or the entire genome.

Test Process

To perform the ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test, we require a DNA sample. This sample can be obtained through a blood sample or cheek swab.

The DNA sample is then sequenced using advanced technology to identify any abnormalities or mutations in the ABCC6 gene.

Report Delivery and Test Department

The report for this genetic test will be delivered within 3 to 4 weeks. The test is conducted in our Genetics department.

Pre Test Information

Before undergoing the ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile.

Test Type and Doctor

This test falls under the category of Vascular Diseases. It is recommended to consult with a General Physician for this test.

Conclusion

The ABCC6 Gene Arterial Calcification Type 2 Generalized Infantile Genetic Test is a valuable tool for diagnosing individuals suspected of having this condition. It can guide medical management, provide prognosis information, and assist in genetic counseling for affected individuals and their families.

Test Name ABCC6 Gene Arterial calcification type 2 generalized infantile Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Vascular Diseases
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ABCC6 Gene Arterial calcification type 2, generalized, infantile NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCC6 Gene Arterial calcification type 2, generalized, infantile NGS Genetic DNA Test gene ABCC6
Test Details

The ABCC6 gene is responsible for producing a protein called the ATP-binding cassette sub-family C member 6. Mutations in this gene can lead to a condition known as arterial calcification type 2, generalized, infantile.

Arterial calcification type 2, generalized, infantile is a rare genetic disorder characterized by abnormal calcification (hardening) of the arteries throughout the body. This can lead to various complications such as narrowing of the blood vessels, reduced blood flow, and increased risk of heart attacks and strokes.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of arterial calcification type 2, generalized, infantile, NGS genetic testing can be used to identify mutations in the ABCC6 gene, providing a definitive diagnosis for individuals suspected of having this condition.

The NGS genetic test involves obtaining a DNA sample, typically through a blood sample or cheek swab. The DNA is then sequenced using advanced technology to identify any abnormalities or mutations in the ABCC6 gene. The results of the test can help guide medical management, provide information about prognosis, and assist in genetic counseling for affected individuals and their families.